Company
Allyx Therapeutics
Pioneering a Synapse Protecting Oral Therapy
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Treating Neurodegenerative Disease by Selectively Blocking the mGluR5 Receptor
Products
- Web
- ALX-001
Loading relationship preview